Exelixis (EXEL) Total Debt (2010 - 2017)
Exelixis (EXEL) posted quarterly Total Debt of $113.3 million for Q1 2017, up 5.44% year-over-year from $107.5 million in Q1 2016, and up 3.87% quarter-over-quarter from $109.1 million in Q4 2016.
Analysis
Exelixis (EXEL) Total Debt (2010 - 2017) Analysis & Trends
Exelixis' Total Debt history runs 8 years deep, the most recent figure standing at $113.3 million for Q1 2017.
- In Q1 2017, Total Debt rose 5.44% year-over-year to $113.3 million; the TTM figure through Mar 2017 stood at $113.3 million (up 5.44% YoY), while the FY2016 annual figure was $109.1 million, up 36.4% from the prior year.
- Total Debt for Q1 2017 stood at $113.3 million, up from $109.1 million in the prior quarter.
- The five-year high for Total Debt was $177.4 million in Q4 2014, with the low at $27.5 million in Q2 2016.
- The 5-year median for Total Debt is $90.8 million (2013), against an average of $99.0 million.
- The sharpest annual moves came in 2014 and 2016: Total Debt surged 96.45% in 2014, then sank 65.62% in 2016.
- Exelixis' Total Debt stood at $90.3 million in 2013, then soared by 96.45% to $177.4 million in 2014, then plunged by 54.92% to $80.0 million in 2015, then jumped by 36.4% to $109.1 million in 2016, then climbed by 3.87% to $113.3 million in 2017.
- Business Quant data shows EXEL's Total Debt at $113.3 million in Q1 2017, $109.1 million in Q4 2016, and $29.4 million in Q3 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 591.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.07 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 9.34 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Exelixis | 14.81 Bn | 13.97 Bn | 608.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 113.35 Mn |
| Dec 30, 2016 | 189.12 Mn |
| Sep 30, 2016 | 109.37 Mn |
| Jun 30, 2016 | 107.50 Mn |
| Mar 31, 2016 | 107.50 Mn |
| Dec 31, 2015 | 80.00 Mn |
| Sep 30, 2015 | 80.45 Mn |
| Jun 30, 2015 | 80.00 Mn |
| Mar 31, 2015 | 84.08 Mn |
| Dec 31, 2014 | 177.83 Mn |
| Sep 30, 2014 | 177.25 Mn |
| Jun 30, 2014 | 175.34 Mn |
| Mar 31, 2014 | 81.61 Mn |
| Dec 31, 2013 | 92.09 Mn |
| Sep 30, 2013 | 92.88 Mn |
| Jun 30, 2013 | 93.68 Mn |
| Mar 31, 2013 | 94.47 Mn |
| Dec 31, 2012 | 95.26 Mn |
| Sep 30, 2012 | 96.05 Mn |
| Jun 30, 2012 | 96.84 Mn |